These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21034302)

  • 21. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
    Guex-Crosier Y; Othenin-Girard P; Herbort CP
    Klin Monbl Augenheilkd; 1992 May; 200(5):367-73. PubMed ID: 1614102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retisert: is the new advance in treatment of uveitis a good one?
    Mohammad DA; Sweet BV; Elner SG
    Ann Pharmacother; 2007 Mar; 41(3):449-54. PubMed ID: 17341531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranibizumab for uveitic macular edema: why?
    Gaudio PA
    Am J Ophthalmol; 2009 Aug; 148(2):179-80. PubMed ID: 19619717
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
    Farvardin M; Afarid M; Mehryar M; Hosseini H
    Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis.
    Das-Bhaumik RG; Jones NP
    Eye (Lond); 2006 Aug; 20(8):934-7. PubMed ID: 16096656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual acuity and foveal thickness after vitrectomy for macular edema.
    Noma H; Funatsu H; Mimura T; Shimada K
    Ophthalmologica; 2010; 224(6):367-73. PubMed ID: 20453544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on treatments of diabetic macular edema.
    Yang XL; Liu K; Xu X
    Chin Med J (Engl); 2009 Nov; 122(22):2784-90. PubMed ID: 19951615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on treatments for diabetic macular edema.
    Fraser-Bell S; Kaines A; Hykin PG
    Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etiology and treatment of macular edema.
    Johnson MW
    Am J Ophthalmol; 2009 Jan; 147(1):11-21.e1. PubMed ID: 18789796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
    Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema.
    Hall J
    Drug Des Devel Ther; 2016; 10():1543-6. PubMed ID: 27217721
    [No Abstract]   [Full Text] [Related]  

  • 38. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
    Soheilian M; Karimi S; Ramezani A; Peyman GA
    Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.